RELATED CONTENT
March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...
March 10, 2025 
Jan. 23, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a new ...
January 23, 2025
Dec. 12, 2024 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, recently announced ...
December 19, 2024
Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...
December 05, 2024
Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...
December 02, 2024
Nov. 8, 2024 — Lunit has announced new research findings demonstrating the potential of its artificial intelligence (AI) ...
November 11, 2024
Oct. 23 , 2024 — Lunit recently announced the findings from two large-scale studies evaluating its AI-powered ...
October 23, 2024
Sept. 9, 2024 — Lunit has announced a collaboration with Roche to integrate Lunit SCOPE PD-L1 22C3 TPS into Roche's ...
September 09, 2024
Aug. 28, 2024 — Rezolut, LLC recently debuted its latest offering for patients during their annual mammogram ...
August 29, 2024
July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...
July 29, 2024
